Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Almost 7% of study participants permanently stopped taking the pill because of adverse effects, compared to almost 6% with a placebo
Our team takes the time to understand your goals, evaluate your hormonal health, and guide you through a safe, sophisticated approach to weight loss and wellness
The medication requires time to reach therapeutic levels, and response varies considerably among individuals based on metabolic factors, adherence patterns, and concurrent health conditions
Presented for research literature review only Smith WA et al
A synthetic 31-amino acid C18 fatty diacid-conjugated GLP-1 analogue and the most extensively characterised long-acting selective glucagon-like peptide-1 receptor agonist research compound available to laboratories in Ireland and a structurally optimised GLP-1(7-37) analogue incorporating Aib8 substitution for DPP-IV resistance, Arg34Lys substitution eliminating a proteolytic site, and a C18 fatty diacid conjugated via a hydrophilic linker to Lys26 enabling tight reversible albumin binding that produces a circulating half-life of about one week and once-weekly pharmacokinetics activating the GLP-1 receptor through canonical Gs-cAMP-PKA-EPAC2 signal transduction in pancreatic beta cells, hypothalamic appetite-regulating nuclei, brainstem nucleus tractus solitarius, cardiac tissue, and peripheral organs to produce glucose-stimulated insulin secretion potentiation, glucagon suppression, gastric emptying inhibition, pronounced central appetite suppression and body weight reduction, beta cell trophic biology, and cardioprotective signalling
US$ 27.17
US$ 26.00
US$ 29.50
US$ 26.74
US$ 23.39
US$ 24.24
US$ 28.45
